03:46 PM EDT, 09/29/2025 (MT Newswires) -- Cosmos Health ( COSM ) said Monday it plans to expand its international presence and scale its branded product and pharmaceutical portfolio, while increasing its investments in blockchain and artificial intelligence, as the company targets to become a "global powerhouse" by 2030.

Cosmos began implementing a $300 million financing facility secured in August, allocating 72.5% of proceeds to a digital treasury reserve including Ethereum, Bitcoin and Solana, with the remainder going toward working capital and acquisitions, Chief Executive Greg Siokas said in a letter to shareholders.

Siokas said he has invested over $18 million in Cosmos and currently holds more than 6 million shares.

For 2027, Cosmos is projecting about $155.8 million in revenue, as well as a positive operating cash flow, driven by branded products, upgraded manufacturing, and distribution expansion, Siokas said.

Cosmos' sales so far in 2025 are tracking close to its forecast, Siokas said, adding that the company's obesity treatment candidate CCX0722 remains on track for a 2026 launch.

Shares of the company fell 1.9% in recent trading.

Price: 1.06, Change: -0.02, Percent Change: -1.85